Epitome Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2M

  • Investors
  • 4

Epitome Therapeutics General Information

Description

Developer of epigenome editing technology designed to advance precision medicine for disease treatment. The company offers editing methods that regulate gene expression without altering DNA sequences, uses proprietary tools to modify epigenetic markers, supports applications in oncology and rare diseases, emphasizes accuracy and safety in clinical development, enabling biotechnology researchers, pharmaceutical firms, and healthcare providers to access novel approaches for disease management, improve therapeutic outcomes, reduce reliance on conventional genetic modification, and integrate epigenome editing into medical practice.

Contact Information

Website
www.epitome-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Drive Bohr-Gasse 7
  • Vienna, 1030
  • Austria
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Digital Health, Life Sciences
Corporate Office
  • Drive Bohr-Gasse 7
  • Vienna, 1030
  • Austria

Epitome Therapeutics Timeline

2026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epitome Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 30-Jun-2026 $2M Completed Startup
3. Grant 30-Jun-2026 Completed Startup
2. Accelerator/Incubator 01-Jan-2026 Completed Startup
1. Spin-Off 01-Jan-2025 Completed Startup
To view Epitome Therapeutics’s complete valuation and funding history, request access »

Epitome Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Epitome Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Caesar Ventures Venture Capital Minority
NAVEC Investment Management Asset Manager Minority
Xista Science Ventures Venture Capital Minority
Creative Destruction Lab Accelerator/Incubator
To view Epitome Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Epitome Therapeutics FAQs

  • When was Epitome Therapeutics founded?

    Epitome Therapeutics was founded in 2025.

  • Where is Epitome Therapeutics headquartered?

    Epitome Therapeutics is headquartered in Vienna, Austria.

  • What is the size of Epitome Therapeutics?

    Epitome Therapeutics has 10 total employees.

  • What industry is Epitome Therapeutics in?

    Epitome Therapeutics’s primary industry is Biotechnology.

  • Is Epitome Therapeutics a private or public company?

    Epitome Therapeutics is a Private company.

  • What is Epitome Therapeutics’s current revenue?

    The current revenue for Epitome Therapeutics is .

  • How much funding has Epitome Therapeutics raised over time?

    Epitome Therapeutics has raised $2M.

  • Who are Epitome Therapeutics’s investors?

    Caesar Ventures, NAVEC Investment Management, Xista Science Ventures, and Creative Destruction Lab have invested in Epitome Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process